Home | Sitemap | Submit Content | Contact Us   
imageHome : Latest News : Evaluation of REVLIMID® in Patients with Either GCB or Non-GCB Diffuse Large B-Cell Lymphoma ... - Yahoo Finance

Evaluation of REVLIMID® in Patients with Either GCB or Non-GCB Diffuse Large B-Cell Lymphoma ... - Yahoo Finance

  • email Email to a friend
  • print Print version

Did you enjoy this article?

(total 0 votes)
Try our own cheap Booking Service45 times read : Adjust font size: Decrease font Enlarge font
image

BOUDRY, Switzerland--(BUSINESS WIRE)-- Celgene International Sàrl (NASDAQ: CELG - News ) today announced researchers at the annual meeting of the American Society of Clinical Oncology presented data from an evaluation ...

Read this article...



Post your comment comment Comments (0 posted)

copyright